Searchable abstracts of presentations at key conferences in endocrinology

ea0081p660 | Pituitary and Neuroendocrinology | ECE2022

Soluble alpha klotho in adult patients with growth hormone deficiency

Ribeiro de Oliveira Longo Schweizer Junia , Schilbach Katharina , Haenelt Michael , Gagliardo Anica , Stormann Sylvere , Schopohl Jochen , Bidlingmaier Martin

Background: We recently have shown a close association of high concentrations of soluble alpha klotho (sαKL) to disease activity in acromegaly. Small pilot studies suggested that sαKL concentrations might be reduced in GH deficiency (GHD) and increase after recombinant human GH (rhGH) therapy. Our aim was to evaluate the potential of sαKL as a biomarker in GHD.Methods: We evaluated sαKL in comparison to the classical biomarkers GH, IG...

ea0093oc11 | Oral communication 2: Neuroendocrinology | EYES2023

Soluble alpha klotho, a new biomarker of growth hormone action

Schweizer Junia Ribeiro de Oliveira Longo , Schilbach Katharina , Gagliardo Anica Pauline , Haenelt Michael , Peters Annette , Thorand Barbara , Bidlingmaier Martin

Background: Soluble alpha klotho (sαKL) is high in active acromegaly, normalizes after disease control, and therefore is suggested as a new biomarker for growth hormone (GH) excess. However, little is known about the impact of biological variables other than GH.Methods: Serum sαKL (pg/ml) was measured by ELISA (IBL, Hamburg, Germany). We first evaluated pre-analytical stability, defined a reference interval for sαKL in healthy subjects (A:...

ea0099p527 | Pituitary and Neuroendocrinology | ECE2024

Soluble alpha klotho concentrations are resistant to short-term stimulation and suppression of growth hormone

Ribeiro de Oliveira Longo Schweizer Junia , Schilbach Katharina , Tausendfreund Olivia , Haenelt Michael , Gagliardo Anica , Schopohl Jochen , Drey Michael , Bidlingmaier Martin

Background: Serum soluble alpha klotho (sαKL) is a circulating protein which had been shown to be very high in active acromegaly, and significantly reduced after disease control. Therefore, sαKL has been suggested as a new biomarker for growth hormone (GH) excess. In this study, we aimed to evaluate the impact of short-term stimulation and suppression of GH and acute modulation of glucose metabolism on sαKL concentrations.Methods: Serum s&...

ea0090p419 | Pituitary and Neuroendocrinology | ECE2023

Reference intervals for soluble alpha klotho and the impact of biological variables

Ribeiro de Oliveira Longo Schweizer Junia , Schilbach Katharina , Haenelt Michael , Pauline Gagliardo Anica , Peters Anette , Thorand Barbara , Stormann Sylvere , Schopohl Jochen , Bidlingmaier Martin

Background: Alpha klotho is a transmembrane protein that regulates calcium metabolism. Its soluble portion has been linked to endocrine functions. We have recently shown high concentrations of serum soluble alpha klotho (sαKL) in active acromegaly. There is limited information about regulation of sαKL secretion. We aimed to gain insight about sαKL as a potential biomarker for H-related diseases.Methods: SαKL was measured by ELISA (IBL...

ea0099p132 | Pituitary and Neuroendocrinology | ECE2024

Is urine sαkl a potential biomarker in acromegaly?

Pauline Gagliardo Anica , Haenelt Michael , Ribeiro de Oliveira Longo Schweizer Junia , Thorsteinsdottir Jun , Teupser Daniel , Schopohl Jochen , Stormann Sylvere , Bidlingmaier Martin , Schilbach Katharina

Background: Soluble alpha klotho (sαKL) is a peptide hormone, that has been shown to be elevated in serum of patients with uncontrolled acromegaly. One early pilot study suggested that sαKL is also detectable in urine from patients with acromegaly, and significantly drops after surgery. Notably, in this study, urine sαKL concentrations were undetectable in the control group, and fell consistently below the detection limit of the ELISA in postoperative patients i...